{"id":1565,"date":"2016-07-29T11:02:38","date_gmt":"2016-07-29T10:02:38","guid":{"rendered":"http:\/\/www.prisma-rt.org\/?page_id=1565"},"modified":"2025-07-04T13:48:47","modified_gmt":"2025-07-04T11:48:47","slug":"publicaties-algemeen","status":"publish","type":"page","link":"https:\/\/www.prisma-rt.nl\/en\/publicaties-algemeen\/","title":{"rendered":"Publicaties algemeen"},"content":{"rendered":"<p>AHRQ<br \/>\n<a href=\"https:\/\/psnet.ahrq.gov\/resources\/resource\/30948\" target=\"_\" rel=\"noopener noreferrer\">Translating concerns into action: a detailed qualitative evaluation of an interdisciplinary intervention on medical wards.<\/a><\/p>\n<p>Elsevier Safety Science<br \/>\n<a href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0925753517303922\" target=\"blank\" rel=\"noopener noreferrer\">The importance of commitment, communication, culture and learning for the implementation of the Zero Accident Vision in 27 companies in Europe<\/a><\/p>\n<p>Chevron<br \/>\n<a href=\"https:\/\/www.chevron.com\/stories\/believing-in-zero\" target=\"blank\" rel=\"noopener noreferrer\">Believing in zero: Chevron&#8217;s relentless focus on safety<\/a><\/p>\n<p>Top 10 ECRI Excecutive Brief 2017<br \/>\n<a href=\"https:\/\/www.prisma-rt.nl\/wp-content\/uploads\/2017\/04\/2017-Top10-ECRI-ExecutiveBrief.pdf\" target=\"blank\" rel=\"noopener noreferrer\">2017 Top10 ECRI ExecutiveBrief<\/a><\/p>\n<p>Top 10 Health Technology Hazards for 2017<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/07\/2017-Top-10-Heath-technology-hazards.pdf\" target=\"blank\" rel=\"noopener noreferrer\">2017 Top 10 Heath Technology Hazards for 2017<\/a><\/p>\n<p>Top 10 Patient Safety Concerns 2016; ECRI-institute<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/10\/2016_Top10_ExecutiveBrief_final.pdf\" target=\"blank\" rel=\"noopener noreferrer\">2016 Top10 Executivebrief final<\/a><\/p>\n<p>Top 10 Health Technology Hazards for 2016; ECRI-institute<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/07\/2016_Top_10_Hazards_Executive_Brief.pdf\" target=\"blank\" rel=\"noopener noreferrer\">2016_top_10_hazards_executive_brief<\/a><\/p>\n<p>Free from Harm 2015; The National Patient Safety Foundation<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/07\/2015-Free_from_Harm.pdf\" target=\"blank\" rel=\"noopener noreferrer\">2015-free_from_harm<\/a><\/p>\n<p>Radiotherapy Risk profile World Health Organization 2008,<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/07\/090715-WHO-radiotherapy_risk_profile.pdf\" target=\"blank\" rel=\"noopener noreferrer\">090715 WHO radiotherapy_risk_profile<\/a><\/p>\n<p>Improving patient safety in radiation oncology; 2010<br \/>\n<a href=\"http:\/\/www.prisma-rt.org\/wp-content\/uploads\/2016\/07\/101217-Hendee_ptsafety_mp10.pdf\" target=\"blank\" rel=\"noopener noreferrer\">101217, Hendee_ptsafety_mp10<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AHRQ Translating concerns into action: a detailed qualitative evaluation of an interdisciplinary intervention on medical wards. Elsevier Safety Science The importance of commitment, communication, culture and learning for the implementation of the Zero Accident Vision in 27 companies in Europe Chevron Believing in zero: Chevron&#8217;s relentless focus on safety Top 10 ECRI Excecutive Brief 2017 2017 Top10 ECRI ExecutiveBrief Top 10 Health Technology Hazards for&#8230; <\/p>\n<p><a class=\"readmore\" href=\"https:\/\/www.prisma-rt.nl\/en\/publicaties-algemeen\/\">Read More<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":"","_tec_slr_enabled":"","_tec_slr_layout":""},"class_list":["post-1565","page","type-page","status-publish","hentry"],"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["nl","en"],"languages":{"nl":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":true,"excerpt":false}}},"ticketed":false,"_links":{"self":[{"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/pages\/1565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/comments?post=1565"}],"version-history":[{"count":33,"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/pages\/1565\/revisions"}],"predecessor-version":[{"id":6436,"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/pages\/1565\/revisions\/6436"}],"wp:attachment":[{"href":"https:\/\/www.prisma-rt.nl\/en\/wp-json\/wp\/v2\/media?parent=1565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}